AO11202
A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy.

GOG-0263
Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation in Intermediate Risk, Stage I/IIA Cervical Cancer Treated with Initial Radical Hysterectomy and Pelvic Lymphadenectomy.

N1048
A Phase II/III Trial of Neoadjuvant FOLFOX, with Selective Use of Combined Modality Chemoradiation Versus Preoperative Combined Modality Chemoradiation for Locally Advanced Rectal Cancer Patients Undergoing Low Anterior Resection with Total Mesorectal Excision.

NSABP B-51/RTOG 1304
A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy.

GENTleMEN Study
Genetic testing for men with metastatic prostate cancer. This study seeks to remove barriers and improve access to genetic testing and counseling, which aren’t available everywhere or always covered by insurance.

Quit2Heal
A randomized trial on the use of smart phone apps to aid in smoking cessation. Candidates must have been diagnosed with cancer in the past 12 months and are current or recently quit smokers (less than 30 days). They will be assigned to one of two apps with the goal of finding the most effective tool/aid.

Survivorship FH2550
A multicenter study to assess late and long-term effects of cancer treatment and to improve and expand care among cancer survivors.